A 25,000ft² increase in production space has enabled technological advances in supplement manufacturing, which includes semi-automatic encapsulation machinery, high-speed machinery and cutting-edge technology. Private Label Nutraceuticals could also
Zytiga (abiraterone acetate) is administered in combination with prednisone to treat patients with metastatic castration-resistant prostate cancer (mCRPC) who are asymptomatic or mildly symptomatic after failure of androgen
STA2R , which is a panel of genetic tests, provides clinicians with new information to select personalized antipsychotic and antidepressant drug. The test also helps clinicians to identify
The decision was made after a recently conducted independent futility analysis concluded HBBN, the second of Lilly’s two pivotal studies, was unlikely to be positive in its primary
The 8,252,328 patent covers delivery of sufentanil using NanoTab technology to a homogenous bioadhesive tablet, comprising from about 2.5 to about 100 micrograms of sufentanil and a volume
The development studies have been funded by The Michael J. Fox Foundation (MJFF) 2011 Pipeline Program to support its ‘Therapeutic Development Initiative.’ PBT434 is an orally administered compound,
With the IND approval, Proacta will begin clinical trial which will focus on patients with non-small cell lung cancer who have developed resistance to reversible tyrosine kinase inhibitors
The issuance of designation from the FDA follows the completion of a Phase IIa study in which N05 demonstrated statistically significant results on the primary and secondary efficacy
JSW provides preclinical and clinical Phase II – IV drug development services including project planning, project management, trial monitoring, database management, data analysis, medical writing and regulatory affairs.
The acquisition will enable Hospira to integrate certain critical beta-lactam antibiotic APIs (penems and penicillins) into its portfolio. In addition, controlling the source of beta-lactam APIs will improve
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.